Company Description
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.
It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions.
The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force.
ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
| Country | United States |
| Founded | 1989 |
| IPO Date | Jun 2, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 9,980 |
| CEO | Michael Farrell |
Contact Details
Address: 9001 Spectrum Center Boulevard San Diego, California 92123 United States | |
| Phone | 858-836-5000 |
| Website | resmed.com |
Stock Details
| Ticker Symbol | RMD |
| Exchange | NYSE |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000943819 |
| CUSIP Number | 761152107 |
| ISIN Number | US7611521078 |
| Employer ID | 98-0152841 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Michael J. Farrell BE, MBA, SM | Chief Executive Officer and Chairman |
| Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus and Director |
| Brett A. Sandercock | Chief Financial Officer |
| Michael J. Rider | Chief Legal Officer and Secretary |
| Justin Leong | Chief Product Officer |
| Kaushik Ghoshal | Chief Commercial Officer - SaaS |
| Alastair Robertson | Chief Information Officer |
| Amy Wakeham | Chief Investor Relations Officer |
| Jim Ellis | Chief Compliance Officer |
| Yvonne-Katrin Pucknat | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 22, 2024 | 144 | Filing |
| Nov 21, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 144 | Filing |
| Nov 8, 2024 | 144 | Filing |
| Nov 7, 2024 | 144 | Filing |
| Nov 6, 2024 | 144 | Filing |
| Nov 1, 2024 | 144 | Filing |
| Oct 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 25, 2024 | 10-Q | Quarterly Report |
| Oct 24, 2024 | 8-K | Current Report |